Health News Archive - May 19, 2011
EAST BRUNSWICK, N.J., May 19, 2011 /PRNewswire/ -- Swissray International, Inc., a leading manufacturer of direct digital Radiography (ddR) systems, announced today that they have sold another ddRFormula DR system to the Orthopedic Associates of Fort Walton Beach., Florida. For more than a decade Swissray has been the pioneer and technology leader in the field of digital radiography (DR) serving hundreds of health care providers and patients with innovative and cost-effective DR solutions that emphasize excellence in image quality and lower radiation dose.
SANTA CLARA, Calif., May 19, 2011 /PRNewswire/ -- Silicon Valley Bank (SVB), financial partner to innovative technology and life science companies worldwide, released a study today that examines the merger and acquisition behavior of private, venture capital-backed biotech and medical device companies. Based on an analysis of private merger or acquisition transactions of US venture-capital backed companies (60 biotech and 58 medical device) since 2005, SVB found several conclusions about investments in life science companies that counter conventional wisdom.
SAO PAULO, May 19, 2011 /PRNewswire/ -- The famous statue of Christ, in Rio de Janeiro is changing colors on May 19th and 20th.
To view the Social Media Release, click here: http://smr.newswire.ca/en/the-tourette-syndrome-foundation-of-canada/launch-the-random-online-documentary-project TORONTO, May 18 /PRNewswire/ - The Tourette Syndrome Foundation of Canada (TSFC) is pleased to introduce @Random, an online documentary project about Tourette Syndrome. Tourette Syndrome is an inherited neurologicalÂ disorder characterized by involuntary tics, that touches over a million lives in North American directly or indirectly.
INDIANAPOLIS, May 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced data from its Phase II study with cixutumumab in five subtypes of sarcoma, a cancer that develops from connective tissues in the body.
INDIANAPOLIS, May 19, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.
AUBURNDALE, Mass., May 19, 2011 /PRNewswire/ -- Advantagene, Inc., a Massachusetts-based biopharmaceutical company, announced today that it reached an agreement with the U.S.
AUSTIN, Texas, May 19, 2011 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a molecular diagnostics company, today announced the appointment of Bruce Huebner to its Board of Directors. Mr. Huebner currently serves as Managing Director at LynxCom Partners, LLC - a Healthcare Consulting Firm. Mr.
FORT WORTH, Texas, May 19, 2011 /PRNewswire/ -- Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions announced the publication of an interview of its President Deborah Jenkins Hutchinson by CEOCFOInterviews.com, a weekly web publication consisting of interviews with CEOs and CFOs of publicly traded growth companies.
- a slit in a tire to drain away surface water and improve traction.